Domo Appears Positioned For The Enterprise AI Era (Upgrade)
Domo's Q3 2025 results beat expectations, although growth remains very slow. Nevertheless, I am upgrading the stock to a ...
Axsome Therapeutics, Inc. (AXSM) Q4 2024 Earnings Call Transcript
Good morning, and welcome to the Axsome Therapeutics Fourth Quarter and Full Year 2024 Conference Call. Currently, all participants are in a listen-only mode. Later, there will be a ...